Identification of peripheral neural circuits that regulate heart rate using optogenetic and viral vector strategies by Rajendran, Pradeep S. et al.
Reviewers' comments:  
 
Reviewer #1 (Remarks to the Author):  
 
This is an interesting manuscript that describes how to use optogenetic approaches to image the 
anatomy of the cardiac nervous system as well as how to use those approaches to dissect functional 
circuits within living heart tissue. There is a nice mix of technology development and mechanistic 
insights via an anatomic/functional analysis of the role of the cardiac IPV-GP. Very nice work is 
presented yet there are multiple areas where the manuscript can be improved, as explained below.  
 
The clearing of mouse hearts using iDISCO is a new development and the results shown in Figure 1 
are impressive. In Figure 1a it is interesting that PGP9.5 staining was done before clearing. Can the 
authors provide data regarding the loss of PGP9.5 immunofluorescence that results from iDISCO (ie, 
fluorescence signals for PFA-fixed then stained tissue compared to stained then iDISCO-cleared 
tissue). It is important to quantify how clearing approaches do or do not affect fluorescent probes.  
 
It is interesting that secondary staining with GFP was required to amplify ChR2-eYFP fluorescence (ie, 
Figure 3a). Is this because iDISCO attenuated the fluorescence of ChR2-eYFP? Please consider recent 
work of Moreno, et al., available on bioRxiv (doi: https://doi.org/10.1101/451450) that reports high 
fluorescence of ChR2-eYFP (without GFP amplification) in a mouse model that is almost identical to 
that used by the authors.  
 
In addition to the Yokoyama 2017 publication please also consider an additional publication that shows 
CLARITY clearing of a mouse heart (Figure 6i in Hsueh, Scientific Reports 2017). Figure 1 of Hsueh 
2017 also reports the amount of protein loss after clearing. How does this compare to iDISCO?  
 
Nearly-selective expression of ChR2 in peripheral neurons was accomplished using AAV-PHP.S to 
provide for specific stimulation of postganglionic cardiac neurons. Nearly-selective expression was 
confirmed via MIP confocal imaging (Supp Figure 2). Additional evidence for the selectivity of this viral 
approach would be to repeat the functional experiments (Supp Figure 2) after severing the cardiac 
vagal inputs, as was done for the experiments shown in Figure 4. Can data from such studies be 
provided?  
 
A large portion of the manuscript is devoted to investigations of cholinergic neurons and the IPV-GP. 
The selectivity of the Cre-Lox system (transgenic model and the viral approach) for expression of 
ChR2 in cholinergic neurons is not assessed in a direct manner. The primary assessment is indirect, in 
that the authors report an overlay of PGP9.5 fluorescence and GFP-amplified ChR2-eYFP fluorescence. 
This is generally convincing yet quantitative assessment of co-location of ChR2-eYFP with ChAT in the 
heart would seal the deal. For example, the Moreno, et al., preprint shows co-localization of ChR2-
eYFP with ChAT in cardiac neurons in a mouse model almost identical to that used by the authors. 
Indeed, the authors used ChAT immunohistochemistry for the dorsal motor nucleus in the medulla 
(Supp Figure 1a) yet there are no ChAT images shown for the cardiac ganglia. Such definitive proof of 
selective expression is particularly important for the ChAT-IRES-Cre transgenic mice transfected with 
AAV-PHP.S  
 
Figure 3c: heart rate appears to be lower after cessation of illumination. Why? At 20Hz stimulation the 
R wave amplitude also drops after cessation of illumination. This is also true for 10Hz in Figure 3i. Is 
this typical? Please report the average response of the hearts after cessation of illumination. Is the 
post-illumination response dependent upon the duration of illumination or other illumination 
parameters?  
 
Figure 6a: heart rate does not return to baseline levels. How long before it does?  
 
For all experiments please report the illumination area. Irradiance values in mW/mm^2 will be more 
informative than the currently reported power levels in mW. What might be the expected levels 
(increase in degC) of tissue warming if the power was directed onto a small area (ie, high irradiance)? 
Could slight warming above physiologic temp increase neuron firing rate and release of 
neurotransmitter?  
 
How does the heart rate response to optical stimulation of the paravertebral ganglia compare to 
electrical stimulation of the ganglia? TH-ChR2-eYFP mice were used for the stellate experiments. It is 
possible that preganglionic neurons in the stellate were also stimulated? Such synapses are 
presumably nicotinic, yet is it safe to assume that there is no expression at all of ChR2 in those 
preganglionic neurons? Could ChAT + TH co-staining reveal the synaptic maps (re: Figure 5) and 
possibly indicate potential cross-over expression of ChR2?  
 
Figures 3e, 3f, 4d, 4e, 4g, 6e, Supp 2b: none of these “dose-response” plots show a plateau or dose 
saturation. Can additional data be added to indicate maximal response levels?  
 
 
 
Reviewer #2 (Remarks to the Author):  
 
This is an interesting and technically impressive study using opticogenetic stimulation and genetic 
labeling to map autonomic innervation of the heart in mice. Inquiry into the anatomy and physiology 
of heart rate and conduction control by the autonomic nervous systems represents some of the oldest 
questions in ‘modern’ biology, and the current study adds some interesting new data. It also offers a 
new twist on these investigations using modern tools that, though technically challenging, may be 
used by others in the future. I have some questions, outlined below, on the fidelity of the systems, 
and whether the differences in optical studies and standard electrical stimulation studies provide true 
insights into the biology of the autonomic system, or may have less exciting, perhaps trivial, 
explanations due to imperfect expression or optical capture in the mouse models. Further comments 
follow:  
 
why is HCN4 immunodetection adequate for defining the SAN/AVN? HCN4 is expressed in other 
cardiac tissues, including atrial myocardium. Furthermore, HCN4 expression may increase in response 
to injury, suggesting this approach could be misleading in the future studies foreshadowed in the 
Results section (e.g. MI and nerve sprouting) describing findings in Fig 1.  
 
Were some neurons PGP9.5-? if so, why, given this is a pan-neuronal marker? if this marker has 
incomplete fidelity, what are the implications for your subsequent conclusions?  
 
Last paragraph, page 5 - Could the lack of AVN conduction effect also mean that labeling and/or 
optical capture were incomplete? How can you rule out these possibilities?  
 
Please show absolute heart rates in addition to percent change  
 
Why is mixed recruitment of efferents/afferents by electrical stimulation more effective at rapidly 
increasing HR compared to optical pacing that is designed to only stimulate a pure population of 
nerves? Fig 4c - Given the relative delay in the optical verus electrical stimulation response, I wonder 
what is the evidence that the slower HR change with optical stimulation is not due to incomplete 
expression of the optically activated channel or a phased or delayed pattern of recruitment? How do 
your results unravel the previous findings re electrical stimulation of the PV ganglia (i.e. bradycardia 
followed by tachycardia), as mentioned in the Discussion?  
 
The post vagotomy experiments with a different response to optical (none) and electrical (HR slowing) 
is fascinating. Nevertheless, i wonder how you can be sure it is not due to lack of adequate 
expression/capture/recruitment using the optical method? For example, an electrode recording 
showing an impulse with optical stimulation in the rostral limb of the severed vagus would strengthen 
your conclusion that the biology, rather than technical aspects of your approach, was driving your 
findings.  
 
Paragraph 2, page 10 - The contrast between findings on sympathetic neurons in canines (post 
ganglionic neurons mostly in the middle cervical ganglia of the PV chain) versus mice (showing a 
craniomedial localization) might be due to species differences.  
Minor  
a minimum of 3 beats is excessively vague, arbitrary and, perhaps, insufficient to represent actual 
rates (i.e. 3 is a small number).  
 
 
 
Reviewer #3 (Remarks to the Author):  
 
In this well-written manuscript the authors present a novel tool for studying the role of 
parasympathetic and sympathetic nervous system in murine cardiac electrophysiology using 
optogenetics. They use parasympathetic and sympathetic specific Cre lines in combination with AAV 
driven fluorescent proteins to visualize the cardiac autonomic nervous system. Moreover, using tissue-
specific ChR2 expression they specifically stimulate either the parasympathetic or sympathetic nervous 
system and investigated the effect on heart rate. The authors conclude to have provided novel insight 
into neural regulation of heart rate and tools for studying neuronal cardiac circuits or neural control of 
other organs.  
 
comments  
 
• The 3D visualizations of the neural circuit anatomy are beautiful but passive (movies showing pre-
defined angles and magnifications), it would be great if the authors could provide files where the user 
can decide at what angle and magnification the 3D reconstructions are visualized. Is this possible? 3D 
pdf for example?  
 
• Figure 2 and labeling of the cholinergic neurons. This part is confusing. Please explain the function of 
the human Synapsin I promotor. What is the reason for using the two component expression system? 
Please elaborate. Why not placing Cre directly under control of the Synapsin I promotor? Figure 2c 
shows results of an entirely different expression system. Please explain. How did the authors verify 
that labeling was indeed restricted to the cholinergic neurons? Low levels of Cre expression outside 
these neurons would generate aspecific labeling. Please provide additional data verifying specificity 
using an independent marker.  
 
• The authors use multiple fluorescent proteins to visualize the parasympathetic nervous system. 
Please explain why.  
 
• Figure 2D. It is unclear how the sections are oriented. I suggest to add an overview section 
indicating the location of the sections shown. Moreover, Hcn4 is used to mark the Sinus node and AV 
node. To me, however, the Hcn4 staining seems stronger outside the areas marked with the dashed 
white lines than inside. The AV node does not seem to be labeled. Please address this issue.  
 
• Page 5. The authors use ChR2-enhanced yellow fluorescent protein but switch to GFP in their 
descriptions, which is confusing. “rostral” is archaic, cranial or anterior is more commonly used.  
 
• Figure 4 C. The authors compare optical stimulation of the right vagal nerve with electrical 
stimulation of the right vagal nerve. The approaches differ in 2 ways. 1) Only a part of the RVNS is 
stimulated optically whereas the whole RVNS is stimulated during electrical stimulation, and 2) optical 
stimulation in itself differs from electrical stimulation. Why didn’t the authors compared electrical 
stimulation with optical stimulation of both the efferent and afferent fibers in the vagal nerve? This 
allows for discriminating the different responses to the different approaches.  
 
• The authors report p wave fractionation during IPV-GP stimulation. Do the authors mean a biphasic 
p wave? It is known that the right and left atrium activation with a delay of about 5 ms. The activation 
wave propagates from the right atrium towards the left atrium via a dorsal myocardial connection. Do 
the authors think this delay between right and left atrium is increased during IPV-GP stimulation? Or 
does IPV-GP stimulation affect atrial conduction?  
 
• Page 5 line 31. The authors mention that the nerve fiber passes through the AV node but does not 
synapse. Where is the nerve going? Was ventricular conduction affected?  
 
• On page 7 Figure 4G is discussed before Figure 4F. Please adjust the figure order to the text.  
 
• On page 8 and Figure 6, please provide validation of the specificity of the TH Cre driver.  
 
• Discussion conclusion 3, it is not clear how the authors arrive at this conclusion. Please better 
explain. “central mechanisms”?  
 
• References: In some cases the author list is abbreviated and in other case it is not. Please adjust to 
the correct style.  
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 6 
We thank the editor and reviewers for their thoughtful review of our manuscript and for the 7 
opportunity to revise our work. We feel that in addressing the comments raised by the reviewers 8 
the manuscript has been significantly improved. 9 
 10 
 11 
Reviewer #1 (Remarks to the Author): 12 
 13 
This is an interesting manuscript that describes how to use optogenetic approaches to image the 14 
anatomy of the cardiac nervous system as well as how to use those approaches to dissect 15 
functional circuits within living heart tissue. There is a nice mix of technology development and 16 
mechanistic insights via an anatomic/functional analysis of the role of the cardiac IPV-GP. Very 17 
nice work is presented yet there are multiple areas where the manuscript can be improved, as 18 
explained below. 19 
 20 
We thank the reviewer for careful reading of the manuscript and providing constructive comments. 21 
We have addressed the reviewer’s comments point-by-point below. 22 
 23 
The clearing of mouse hearts using iDISCO is a new development and the results shown in Figure 24 
1 are impressive. In Figure 1a it is interesting that PGP9.5 staining was done before clearing. Can 25 
the authors provide data regarding the loss of PGP9.5 immunofluorescence that results from 26 
iDISCO (ie, fluorescence signals for PFA-fixed then stained tissue compared to stained then 27 
iDISCO-cleared tissue). It is important to quantify how clearing approaches do or do not affect 28 
fluorescent probes. 29 
 30 
We performed additional experiments to compare hearts that were whole-mount stained (fixation 31 
followed by staining) and hearts that underwent the iDISCO protocol. The whole-mount stained 32 
hearts and iDISCO-cleared hearts were stained identically with the same concentrations of 33 
antibodies and for the same duration of time. In both whole-mount stained hearts and iDISCO 34 
cleared hearts, we observed dense innervation and similar patterns of PGP9.5 labeling on the 35 
epicardial surface (Supplemental Figure 1b and d). Importantly, following the iDISCO protocol, 36 
small nerve fiber bundles were preserved. The advantage of the iDISCO protocol versus whole-37 
mount staining is the ability to label and visualize molecular and cellular structures in large tissue 38 
volumes1. In whole-mount stained hearts we were able to visualize fibers only within the first 100-39 
200 µm of the epicardium (Supplemental Figure 1b), whereas in iDISCO-cleared hearts we were 40 
able to visualize fibers throughout the entire thickness of the myocardium from epi- to 41 
endocardium (Supplemental Figure 1d and Supplemental Movie 3). 42 
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 1 
Supplemental Figure 1. Whole-mount stained heart versus iDISCO-cleared heart. (a) A heart 2 
before (top) and after (bottom) whole-mount staining. (b) 3D confocal projection of the dorsal side 3 
of a heart (2000 µm z-stack) whole-mount stained with PGP9.5 (gray). Insets show a MIP image 4 
of the left ventricular wall (top right) and a 1000 µm-thick 3D projection of the left ventricular wall 5 
(bottom right). (c) A whole heart (top) was rendered transparent (bottom) using the iDISCO 6 
protocol. (d) 3D confocal projection of the dorsal side of an iDISCO-cleared heart (2000 µm z-7 
stack) stained with PGP9.5 (gray). Insets show a MIP image of the left ventricular wall (top right) 8 
and a 1000 µm-thick 3D projection of the left ventricular wall (bottom right). In contrast to whole-9 
mount stained hearts, nerve fibers could be visualized throughout the entire thickness of 10 
myocardium in iDISCO-cleared hearts. Scale bars are 2 mm (a, c), 1 mm (b (left), d (left)), and 11 
100 µm (b (right), d (right)). 12 
 13 
Fluorescence intensity was lower in the iDISCO-cleared hearts as compared to the whole-mount 14 
stained hearts (Response Figure 1). However, we cannot comment on whether this is due to a 15 
loss of protein or the fact that antibodies penetrate much deeper (and, therefore, do not saturate 16 
antigen binding sites on the surface) in iDISCO-cleared tissues. Regardless, we do not see this 17 
as a major limitation of using iDISCO for characterizing innervation of the heart. 18 
 19 
 
3 
 1 
Response Figure 1. Fluorescence intensity in whole-mount stained hearts versus iDISCO-2 
cleared hearts. (a) Representative MIP confocal images from the base of a whole-mount stained 3 
heart and an iDISCO-cleared heart with PGP9.5 staining (gray). (b) Mean PGP9.5 intensity from 4 
the base of whole-mount stained hearts versus iDISCO-cleared hearts (t6 = 3.119; *P = 0.0206). 5 
Note staining conditions were identical across all hearts and microscope laser settings remained 6 
constant across all images. n = 4 hearts (b). mean ± s.e.m.; unpaired, two-tailed t-test. Scale bar 7 
is 100 µm (a). 8 
 9 
It is interesting that secondary staining with GFP was required to amplify ChR2-eYFP 10 
fluorescence (ie, Figure 3a). Is this because iDISCO attenuated the fluorescence of ChR2-eYFP? 11 
Please consider recent work of Moreno, et al., available on bioRxiv 12 
(doi: https://doi.org/10.1101/451450) that reports high fluorescence of ChR2-eYFP (without GFP 13 
amplification) in a mouse model that is almost identical to that used by the authors. 14 
 15 
The iDISCO protocol was developed for immunostaining applications1, in contrast to other tissue 16 
clearing techniques such as ScaleA22, 3DISCO3, SeeDB4, CLARITY5,6 (Supplemental Figure 2), 17 
and CUBIC7 that are better suited for imaging endogenous fluorescence. The dehydration 18 
processes and use of dibenzyl ether as an optical clearing agent in the iDISCO protocol are known 19 
to attenuate endogenous fluorescence1. 20 
 21 
In our manuscript, the hearts in Figure 1, Supplemental Figure 1, and Supplemental Movies 1-3 22 
were immunostained with the pan-neuronal marker PGP9.5 and cleared with the iDISCO protocol 23 
as we were interested in characterizing innervation of entire hearts in 3D. However, the tissues in 24 
Figures 2-6 and Supplemental Figures 3 and 4 were whole-mount stained (as described in the 25 
Methods section under Immunohistochemistry) and not cleared using the iDISCO protocol as our 26 
goal was to confirm ChR2-eYFP expression in defined cell types (i.e. ChAT and TH neurons). We 27 
have clarified in the figure legends whether tissues were iDISCO-cleared or whole-mount stained. 28 
The tissues from ChAT-ChR2-eYFP and TH-ChR2-eYFP mice were stained with a widely-used 29 
antibody against GFP (Aves Labs, GFP-1020; 545 citations on CiteAb) to amplify the detection of 30 
the endogenous ChR2-eYFP protein and improve the signal-to-noise ratio. As shown in Response 31 
Figure 2, endogenous ChR2-eYFP signals were weak compared to those of GFP, even when 32 
using much higher laser power (100% laser power for imaging endogenous ChR2-eYFP versus 33 
6% laser power for imaging GFP). Additionally, the use of high laser power results in more 34 
background autofluorescence. 35 
 36 
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 1 
Response Figure 2. ChR2-eYFP versus GFP signals in cardiac ganglia. Confocal images 2 
showing native ChR2-eYFP signal versus GFP staining, along with PGP9.5 staining, from the 3 
cardiac ganglia of a ChAT-ChR2-eYFP mouse. Inset shows higher magnification image of a 4 
cardiac ganglion. Note ChR2-eYFP signal was imaged at 100% laser power and GFP was imaged 5 
at 6% laser power for all images. Background autofluorescence from myocardial tissue is 6 
observed in upper left ChR2-eYFP panel and weak signals are observed in lower left ChR2-eYFP 7 
panel likely due to photobleaching. Scale bars are 100 µm (upper panels) and 50 µm (lower 8 
panels). 9 
 10 
We thank the reviewer for bring to our attention the manuscript by Moreno and colleagues. In the 11 
manuscript by Moreno et al., endogenous ChR2-eYFP fluorescence was imaged from a small 12 
volume of the atria. However, in our manuscript, we were concerned about background 13 
autofluorescence and photobleaching resulting from use of high laser power to image 14 
endogenous ChR2-eYFP signals over large tissues volumes such as entire hearts; thus, tissues 15 
were stained with an antibody against GFP. 16 
 17 
In addition to the Yokoyama 2017 publication please also consider an additional publication that 18 
shows CLARITY clearing of a mouse heart (Figure 6i in Hsueh, Scientific Reports 2017). Figure 19 
1 of Hsueh 2017 also reports the amount of protein loss after clearing. How does this compare to 20 
iDISCO?  21 
 22 
Although protein loss with iDISCO has not been previously reported1,8,9, Reiner et al. compared 23 
FoxP2 expression in the inferior olive of an iDISCO-cleared adult mouse brain with tissue sections 24 
from the same level in the original iDISCO manuscript1. The Fox2P expression pattern and the 25 
number of Fox2P-positive cells was consistent between the two methods and other publications. 26 
In addition, our data show similar patterns of PGP9.5 expression between whole-mount stained 27 
hearts and iDISCO-cleared hearts, including preservation of smaller fiber bundles (Supplemental 28 
Figure 1). Taken together, this suggests that protein loss is not a major limitation of using the 29 
iDISCO protocol for characterizing innervation of the heart. 30 
 31 
 32 
 
5 
Nearly-selective expression of ChR2 in peripheral neurons was accomplished using AAV-PHP.S 1 
to provide for specific stimulation of postganglionic cardiac neurons. Nearly-selective expression 2 
was confirmed via MIP confocal imaging (Supp Figure 2). Additional evidence for the selectivity 3 
of this viral approach would be to repeat the functional experiments (Supp Figure 2) after severing 4 
the cardiac vagal inputs, as was done for the experiments shown in Figure 4. Can data from such 5 
studies be provided? 6 
 7 
In the mouse heart, cardiac ganglia are located on the dorsal surface around the pulmonary veins 8 
(Figures 1c and 3a)10-12. It is not possible to expose them surgically in vivo. Therefore, the 9 
experiments in Figure 3 and Supplemental Figure 4 (old Supplemental Figure 2) in which the 10 
inferior pulmonary vein-ganglionated plexus (IPV-GP) was optogenetically stimulated were 11 
performed in ex vivo Langendorff-perfused hearts (as indicated in the figure legends and 12 
described in the Methods section under Optogenetic stimulation and physiological 13 
measurements), whereas the experiments in Figure 4 in which the cervical vagus nerve was 14 
optogenetically stimulated were performed in vivo. In Figure 3 and Supplemental Figure 4 (old 15 
Supplemental Figure 2), when excising the heart from the thorax for the Langendorff preparation, 16 
vagal preganglionic fibers originating from the medulla in the brainstem were indeed transected. 17 
However, even after transection, the caudal end of the vagus nerve, which contains preganglionic 18 
fibers, can still be stimulated in vivo (Figure 4e) and in Langendorff-perfused hearts13,14. 19 
 20 
In addition to viral transduction efficiency, another potential reason for the smaller bradycardic 21 
response observed with optogenetic stimulation of the IPV-GP in Supplemental Figure 4 (old 22 
Supplemental Figure 2) compared to that in Figure 3 is that in ChAT-IRES-Cre mice injected with 23 
AAV-PHP.S:CAG-DIO-ChR2-eYFP only postganglionic cholinergic neurons were transduced 24 
(Supplemental Figure 3 (old Supplemental Figure 1)) and optogenetically stimulated, whereas in 25 
ChAT-ChR2-eYFP mice both vagal preganglionic fibers and postganglionic cholinergic neurons 26 
expressed ChR2-eYFP and were stimulated. Future studies will focus on leveraging engineered 27 
AAVs such as AAV-PHP.S15-17 to selectively transduce defined cell types in the peripheral nervous 28 
system. 29 
 30 
A large portion of the manuscript is devoted to investigations of cholinergic neurons and the IPV-31 
GP. The selectivity of the Cre-Lox system (transgenic model and the viral approach) for 32 
expression of ChR2 in cholinergic neurons is not assessed in a direct manner. The primary 33 
assessment is indirect, in that the authors report an overlay of PGP9.5 fluorescence and GFP-34 
amplified ChR2-eYFP fluorescence. This is generally convincing yet quantitative assessment of 35 
co-location of ChR2-eYFP with ChAT in the heart would seal the deal. For example, the Moreno, 36 
et al., preprint shows co-localization of ChR2-eYFP with ChAT in cardiac neurons in a mouse 37 
model almost identical to that used by the authors. Indeed, the authors used ChAT 38 
immunohistochemistry for the dorsal motor nucleus in the medulla (Supp Figure 1a) yet there are 39 
no ChAT images shown for the cardiac ganglia. Such definitive proof of selective expression is 40 
particularly important for the ChAT-IRES-Cre transgenic mice transfected with AAV-PHP.S 41 
 42 
Most, if not all, commercially available antibodies against ChAT recognize a central rather than 43 
peripheral isoform of ChAT, labeling peripheral cholinergic neurons weakly18. An antibody has 44 
been developed against the peripheral isoform of ChAT19; however, it is not yet commercially 45 
available. Therefore, we used an antibody against ChAT in the medulla in the central nervous 46 
system and an antibody against PGP9.5 as a surrogate for ChAT in cardiac ganglia in the 47 
peripheral nervous system due to the weak labeling and high background associated with ChAT 48 
staining in the periphery. 49 
 50 
 
6 
We performed additional immunohistochemistry to address the reviewer’s comment. Please see 1 
Response Figure 3 and Supplemental Figure 3 (old Supplemental Figure 1). In ChAT-IRES-Cre 2 
mice injected with ssAAV-PHP.S:CAG-DIO-eYFP, we observed strong co-localization of 3 
endogenous ChR2-eYFP with GFP and ChAT staining in cardiac ganglion neurons (Response 4 
Figure 3). The virus was highly efficient at transducing peripheral neurons in cardiac ganglia (91.0 5 
 1.5) versus central neurons in the dorsal motor nucleus of the vagus (1.5  0.9%) (Supplemental 6 
Figure 3b and e). Expression was also highly specific for cholinergic neurons in cardiac ganglia 7 
(100  0% of GFP+ neurons were ChAT+) (Supplemental Figure 3d and e). 8 
 9 
 10 
Response Figure 3. ssAAV-PHP.S:CAG-DIO-eYFP was systemically administered to ChAT-11 
IRES-Cre mice at 1 x 1012 vg per mouse. Three weeks later, eYFP fluorescence was assessed. 12 
Representative single-plane confocal images of a cardiac ganglion with native eYFP signal 13 
(green) and ChAT (red) and GFP (magenta) staining. Scale bar is 50 µm. 14 
 15 
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 1 
Supplemental Figure 3. AAV-PHP.S preferentially transduces peripheral versus central 2 
cholinergic neurons. ssAAV-PHP.S:CAG-DIO-eYFP was systemically administered to ChAT-3 
IRES-Cre mice at 1 x 1012 vg per mouse. Three weeks later, eYFP fluorescence was assessed 4 
using an antibody for GFP. (a) Single-plane confocal images of the medulla (left) and dorsal motor 5 
nucleus of the vagus nerve (DMV) (right) whole-mount stained with ChAT (red) and GFP (green). 6 
White dashed ovals in the medulla show the location of the DMV. White dashed boxes in the DMV 7 
images indicate location of higher magnification images in white boxes. (b) Percentage of DMV 8 
neurons expressing GFP and ChAT over those expressing ChAT. (c) MIP images of the 9 
nodose/jugular ganglion complex whole-mount stained with PGP9.5 (red) and GFP (green). (d) 10 
MIP images of a cardiac ganglion from a heart whole-mount stained with PGP9.5 (red) and GFP 11 
(green). White dashed boxes indicate location of higher magnification images in white boxes. (e) 12 
Percentage of cardiac ganglion neurons expressing GFP and ChAT over those expressing GFP 13 
or ChAT, indicating specificity or efficiency of viral transduction, respectively. n = 4 mice (b) and 14 
 
8 
5 mice (e); mean ± s.e.m.. Scale bars are 500 µm (a (left)), 100 µm (a (right), c, d (right), and 1 1 
mm (d (left)). 2 
 3 
Figure 3c: heart rate appears to be lower after cessation of illumination. Why? At 20Hz stimulation 4 
the R wave amplitude also drops after cessation of illumination. This is also true for 10Hz in Figure 5 
3i. Is this typical? Please report the average response of the hearts after cessation of illumination. 6 
Is the post-illumination response dependent upon the duration of illumination or other illumination 7 
parameters? 8 
 9 
Following optogenetic stimulation of the IPV-GP, heart rate returned to baseline within 16.6 ± 4.4 10 
s at 10 Hz and within 13.1 ± 2.7 s at 20 Hz (Response Figure 4c). These recovery times are in 11 
line with those reported by Moreno et al. (5 - 10 s; doi: https://doi.org/10.1101/451450). The heart 12 
rate recovery was not dependent on frequency or pulse width of stimulation. The duration of 13 
stimulation was 10 s and was not varied during the experiments. The absolute and relative change 14 
in heart rate at baseline, during stimulation, and following stimulation are shown in Response 15 
Figure 4a, b, d and e. 16 
 17 
 18 
Response Figure 4. Heart rate recovery following optogenetic stimulation of cholinergic 19 
neurons in the IPV-GP. (a, b) Summary of the effects of altering stimulation frequency on the 20 
absolute (a) and delta heart rate response (b) before, during, and following optogenetic 21 
stimulation of the IPV-GP at 10 ms and 221 mW. (c) Summary of the time to recovery to baseline 22 
heart rate from a and b (F (1.470, 5.881) = 4.503, P = 0.0716). (d, e) Summary of the effects of 23 
altering stimulation pulse width on the absolute (d) and delta heart rate response (e) before, 24 
during, and following stimulation at 10 Hz and 221 mW. (f) Summary of the time to recovery to 25 
baseline heart rate from d and e (F (1.245, 4.981) = 0.3002, P = 0.6557). n = 6 mice (a-f). mean 26 
± s.e.m.; mixed-effects ANOVA. 27 
 28 
We used two electrodes in the bath to record a pseudo-electrocardiogram (ECG) and a 29 
quadripolar electrophysiology (EP) catheter in the left atrium and ventricle to record intracardiac 30 
electrograms. The change in R wave amplitude following stimulation is likely due to cardiac 31 
 
9 
motion—movement of the heart between the ECG electrodes and movement of the EP catheter 1 
within the heart. The change in R wave amplitude had no effect on any of our measurements. 2 
 3 
Figure 6a: heart rate does not return to baseline levels. How long before it does? 4 
 5 
Following optogenetic stimulation of the right stellate ganglion, heart rate returned to baseline 6 
within 18.9 ± 7.6 s at 10 Hz and 31.9 ± 13.7 s at 20 Hz (Response Figure 5c). Heart rate did not 7 
return to baseline in 2/7 mice at 10 Hz and 1/7 mice at 20 Hz. However, we waited for heart rate 8 
to stabilize before continuing the experimental protocol. The absolute and relative change in heart 9 
rate at baseline, during stimulation, and following stimulation are shown in Response Figure 5a, 10 
b, d and e. 11 
 12 
 13 
Response Figure 5. Heart rate recovery following optogenetic stimulation of noradrenergic 14 
neurons in the right stellate ganglion (RSG). (a, b) Summary of the effects of altering 15 
stimulation frequency on the absolute (a) and delta heart rate response (b) before, during, and 16 
following optogenetic stimulation of the RSG at 10 ms and 126 mW. (c) Summary of the time to 17 
recovery to baseline heart rate from a and b (F (1.673, 7.945) = 2.607, P = 0.1386). (d, e) 18 
Summary of the effects of altering stimulation pulse width on the absolute (d) and delta heart rate 19 
response (e) before, during, and following stimulation at 10 Hz and 126 mW. (f) Summary of the 20 
time to recovery to baseline heart rate from d and e (F (1.029, 3.088) = 3.591, P = 0.1521). n = 7 21 
mice (a-c) and 5 mice (d-f). mean ± s.e.m.; mixed-effects ANOVA. 22 
 23 
 24 
 25 
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For all experiments please report the illumination area. Irradiance values in mW/mm^2 will be 1 
more informative than the currently reported power levels in mW. What might be the expected 2 
levels (increase in degC) of tissue warming if the power was directed onto a small area (ie, high 3 
irradiance)? Could slight warming above physiologic temp increase neuron firing rate and release 4 
of neurotransmitter? 5 
 6 
Laser power was reported rather than irradiance because it is difficult to accurately measure the 7 
area of tissue illuminated. For all experiments, the optical fiber was positioned directly above (<1-8 
2 millimeters) the tissue of interest. Laser power at the tip of the optical fiber was measured with 9 
an optical power meter. 10 
 11 
In our Langendorff experiments, the temperature increase at the tip of the laser-coupled optical 12 
fiber at 221 mW, 20 Hz, and 10 ms was 1.1 ± 0.0 C, which is well below the 6-10 C increase in 13 
temperature that has been reported to be necessary for peripheral nerve stimulation20. We 14 
performed additional experiments to determine whether this increase in temperature could result 15 
in neuronal firing. In Langendorff-perfused wild-type mouse hearts in which there was no 16 
expression of ChR2, an optical fiber was positioned for focal illumination of the IPV-GP. The IPV-17 
GP was stimulated at 221 mW, 20 Hz, and 10 ms. There was no change in heart rate with 18 
stimulation (Response Figure 6a and b). Using the same stimulation parameters in ChAT-ChR2-19 
eYFP mice, heart rate decreased by 50.0 ± 14.9%. These data indicate that the slight increase in 20 
temperature was not responsible for neuronal firing in our preparation. 21 
 22 
 23 
Response Figure 6. Heart rate response to optogenetic stimulation of the IPV-GP in wild-24 
type and ChAT-ChR2-eYFP mouse hearts. A laser-coupled optical fiber was positioned for focal 25 
illumination of the IPV-GP in Langendorff-perfused wild-type versus ChAT-ChR2-eYFP mouse 26 
hearts. (a, b) Summary of the absolute (a) and delta heart rate response (b) to optogenetic 27 
stimulation of wild-type versus ChAT-ChR2-eYFP mouse hearts at 20 Hz, 10 ms, and 221 mW 28 
(t4 = 0.5979, P = 0.5821 for wild-type baseline versus stimulation; t4 = 3.033, *P = 0.0387 for 29 
ChAT-ChR2-eYFP baseline versus stimulation; t8 = 3.470, **P = 0.0084 for wild-type versus 30 
ChAT-ChR2-eYFP). n = 5 mice (a, b). mean ± s.e.m.; paired, two-tailed t-test (a) and unpaired, 31 
two-tailed t-test (b). 32 
 33 
How does the heart rate response to optical stimulation of the paravertebral ganglia compare to 34 
electrical stimulation of the ganglia? 35 
 36 
We performed additional experiments to compare electrical stimulation of the RSG in wild-type 37 
mice to optical stimulation in TH-ChR2-eYFP mice (Response Figure 7). In TH-ChR2-eYFP mice, 38 
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a laser-coupled optical fiber was positioned above the RSG for focal optical stimulation (as 1 
described in the Methods under Optogenetic stimulation and physiological measurements). In 2 
wild-type mice, a concentric bipolar electrode (FHC, 30324) coupled to a constant current 3 
stimulator (Grass, PSIU6 and Model S88) was positioned above the RSG for electrical stimulation. 4 
The current for electrical stimulation in wild-type mice was titrated to achieve an increase in heart 5 
rate at 10 Hz and 10 ms equivalent to that of optical stimulation at 126 mW, 10 Hz, and 10 ms in 6 
TH-ChR2-eYFP mice, which was defined as threshold current. The threshold current was 72  9 7 
µA. The frequency and pulse width response curves for optical versus electrical stimulation of the 8 
RSG were not significantly different. 9 
 10 
 11 
Response Figure 7. In vivo optogenetic versus electrical stimulation of the RSG. (a) Cartoon 12 
depicting optogenetic and electrical RSG stimulation strategy in TH-ChR2-eYFP and wild-type 13 
mice, respectively. The right paravertebral chain was surgically exposed in anesthetized mice and 14 
either light or electricity was used for RSG stimulation. (b) Frequency response curves 15 
summarizing the effects of optogenetic versus electrical RSG stimulation at 10 ms (t11 = 0.2395, 16 
P = 0.8151 at 1 Hz; t11 = 0.06439, P = 0.9498 at 2 Hz; t11 = 0.1467, P = 0.8860 at 5 Hz; t11 = 17 
0.4398, P = 0.6686 at 10 Hz; and t11 = 2.050, P = 0.0650 at 20 Hz for optical versus electrical). 18 
(c) Pulse width response curves summarizing the effects of optogenetic versus electrical RSG 19 
stimulation at 10 Hz (t8 = 1.047, P = 0.3255 at 1 ms; t9 = 0.6464, P = 0.5342 at 2 ms; t9 = 0.3787, 20 
P = 0.7137 at 5 ms; and t9 = 0.4506, P = 0.6629 at 10 ms for optical versus electrical). n = 7 mice 21 
(b optical), 6 mice (b electrical, c optical), and 5 mice (c electrical). mean ± s.e.m.; paired, two-22 
tailed t-test. T2G, second thoracic ganglion. 23 
 24 
TH-ChR2-eYFP mice were used for the stellate experiments. It is possible that preganglionic 25 
neurons in the stellate were also stimulated? Such synapses are presumably nicotinic, yet is it 26 
safe to assume that there is no expression at all of ChR2 in those preganglionic neurons? Could 27 
ChAT + TH co-staining reveal the synaptic maps (re: Figure 5) and possibly indicate potential 28 
cross-over expression of ChR2? 29 
 30 
While it is possible that there was non-specific expression of ChR2-eYFP in TH-ChR2-eYFP mice, 31 
our functional data suggest that sympathetic preganglionic fibers within the paravertebral chain 32 
did not express ChR2-eYFP. As the reviewer indicates, sympathetic preganglionic neurons are 33 
cholinergic21 and ChR2-eYFP expression in TH-ChR2-eYFP mice should be restricted to neurons 34 
that express TH. Sympathetic preganglionic neurons that project to sympathetic postganglionic 35 
neurons innervating the heart are located in the T1-T6 segments of the spinal cord22. Axons from 36 
these sympathetic preganglionic neurons exit the ventral rami of the spinal cord and course up 37 
and down the paravertebral chain to synapse predominately on neurons in the craniomedial 38 
stellate ganglia (Figure 5c and d), which then project to the heart. Previous studies in large 39 
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animals have shown that electrical stimulation of the T1-T2 region of the paravertebral chain, 1 
which contains both sympathetic pre- and postganglionic fibers, elicits an increase in heart 2 
rate23,24. In our studies, optogenetic stimulation of the right stellate ganglion resulted in an increase 3 
in heart rate, whereas there was no response to stimulation of the right T2 ganglion and 4 
sympathetic preganglionic fibers that course through that region (Figure 6g). Therefore, we 5 
believe that the tachycardic response from right stellate ganglion stimulation was due to activation 6 
of postganglionic neurons projecting to the heart not preganglionic fibers. 7 
 8 
Figures 3e, 3f, 4d, 4e, 4g, 6e, Supp 2b: none of these “dose-response” plots show a plateau or 9 
dose saturation. Can additional data be added to indicate maximal response levels? 10 
 11 
The stimulation parameters for all the experiments were chosen based on previous studies of 12 
electrical25-28 and optogenetic stimulation29-31 of the cardiac autonomic nervous system. 13 
 14 
 15 
Reviewer #2 (Remarks to the Author): 16 
 17 
This is an interesting and technically impressive study using opticogenetic stimulation and genetic 18 
labeling to map autonomic innervation of the heart in mice. Inquiry into the anatomy and 19 
physiology of heart rate and conduction control by the autonomic nervous systems represents 20 
some of the oldest questions in ‘modern’ biology, and the current study adds some interesting 21 
new data. It also offers a new twist on these investigations using modern tools that, though 22 
technically challenging, may be used by others in the future. I have some questions, outlined 23 
below, on the fidelity of the systems, and whether the differences in optical studies and standard 24 
electrical stimulation studies provide true insights into the biology of the autonomic system, or 25 
may have less exciting, perhaps trivial, explanations due to imperfect expression or optical 26 
capture in the mouse models.  27 
 28 
We thank the reviewer for thorough reading of the manuscript and insightful comments. We have 29 
addressed the reviewer’s comments point-by-point below. 30 
 31 
Further comments follow: 32 
 33 
Why is HCN4 immunodetection adequate for defining the SAN/AVN? HCN4 is expressed in other 34 
cardiac tissues, including atrial myocardium. Furthermore, HCN4 expression may increase in 35 
response to injury, suggesting this approach could be misleading in the future studies 36 
foreshadowed in the Results section (e.g. MI and nerve sprouting) describing findings in Fig 1. 37 
 38 
The SA node and AV node were identified by a combination of anatomical landmarks (i.e., sulcus 39 
terminalis and superior vena cava for the SA node; base of the right atrium and interatrial septum 40 
for AV node) and HCN4 immunodetection. 41 
 42 
HCN channels are expressed in cardiac and neural tissues and conduct the If current in heart and 43 
Ih current in neural tissues. As the reviewer correctly states, HCN4 is expressed in various cardiac 44 
tissues. However, while expression of the HCN1, HCN2 and HCN4 isoforms has been described 45 
in pacemaker cells, studies across many vertebrates indicate that HCN4 is the most highly 46 
expressed isoform in the SA node. For example, in the rabbit SA node, HCN4 comprises >81% 47 
of the HCN isoforms32.  Genetic mutations in HCN4 have been shown to cause sinus node 48 
dysfunction in humans33-36. An expression study that evaluated the distribution of HCN transcript 49 
in the mouse heart indicates that 59% of the HCN transcript in the SAN is HCN4, while only 6% 50 
and 11% of HCN transcripts in the LA and RA, respectively, are HCN437. Functionally, HCN4 is 51 
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also required for the generation of mature pacemaker potentials in the developing SA node during 1 
embryogenesis in mice and contributes to the majority of the SAN If at around 70-80%38-40. HCN1 2 
is also expressed in the cardiac conduction system and does contribute to a component of If in 3 
the SAN41, but is expressed in 73% of the LA and 58% of the RA in the mouse heart37, making it 4 
less specific for the SA node. HCN2 is the dominant HCN transcript in ventricular myocardium.  5 
 6 
Regarding the AV node, HCN4 has been shown to be expressed in the rabbit42, rat43 and human44. 7 
In humans, HCN4 is the most highly expressed HCN transcript in the AV conduction axis but 8 
below detection threshold in working myocardium44. The expression pattern of the HCN channels 9 
in the AVN has been shown to be similar to that of the SAN in mouse37. In addition, HCN4 is the 10 
target in mouse models for conditional knockout of a gene specific for the cardiac conduction 11 
system39. Based on the literature above, HCN4 appears to be the most highly expressed HCN 12 
isoform and specific marker of the cardiac conduction system including the SA and AV nodes 13 
across vertebrates. For these reasons, we utilized HCN4 immunodetection, in addition to well-14 
known anatomical landmarks, to identify the SA and AV nodes in the mouse heart. 15 
 16 
While increased channel expression and activity of HCN channels (particularly the HCN2 isoform) 17 
have been demonstrated in response to inflammation and neural injury in the peripheral nervous 18 
system, this has not been shown to be the case with myocardial injury or HCN4 channels, to our 19 
knowledge45-52. In future studies, upregulation of HCN channel expression could be assessed in 20 
neural tissues by co-localization of our pan-neuronal marker with HCN as well as in cardiac tissue 21 
by counterstaining with a myocyte marker. 22 
 23 
Were some neurons PGP9.5-? if so, why, given this is a pan-neuronal marker? If this marker has 24 
incomplete fidelity, what are the implications for your subsequent conclusions? 25 
 26 
PGP9.5 is a cytoplasmic neuron-specific protein53 and is widely used as a pan-neuronal marker 27 
including in studies of cardiac innervation54-59. In our studies, we did not observe any neurons in 28 
cardiac ganglia or nodose ganglia that were PGP9.5-. 29 
 30 
Last paragraph, page 5 - Could the lack of AVN conduction effect also mean that labeling and/or 31 
optical capture were incomplete? How can you rule out these possibilities? 32 
 33 
While we cannot rule out that the lack of effect on AV conduction with optogenetic stimulation of 34 
the IPV-GP was due to incomplete expression of ChR2 or optical capture, our data suggest that 35 
this is not case. Almost all PGP9.5+ neurons (96.4  1.2%) in the cardiac ganglia of ChAT-ChR2-36 
eYFP mice were GFP+ (Figure 3b). The IPV-GP was also identified under a fluorescent 37 
stereomicroscope and a laser-coupled optical fiber was positioned above the ganglion for focal 38 
illumination. Further, since we were directly stimulating the cell bodies in the ganglion, fibers 39 
originating from this ganglion and potentially projecting to the AV node should have also been 40 
activated. Nonetheless, we have added a Limitation section in which this is mentioned. 41 
 42 
Please show absolute heart rates in addition to percent change. 43 
 44 
Absolute heart rate, in addition to the relative changes in heart rate, has now been added for all 45 
experiments in Supplemental Tables 1-3. 46 
 47 
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 1 
Supplemental Table 1. Ex vivo optogenetic stimulation of cholinergic neurons in the IPV-2 
GP. Table corresponds to Figure 3. Dose response curves summarizing the effects of altering 3 
light pulse power, frequency, and pulse width on heart rate. Summary of the heart rate response 4 
to stimulation before versus after atropine administration (t4 = 2.993, *P = 0.0402). mean ± s.e.m.; 5 
paired, two-tailed t-test. 6 
 7 
Power (mW)
(n  = 6)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
0 355.8 ± 37.7 355.1 ± 38.0 -0.2 ± 0.2
38 365.8 ± 34.1 307.2 ± 46.1 -16.0 ± 8.7
115 353.0 ± 35.4 228.3 ± 23.7 -31.8 ± 11.0
226 379.2 ± 35.6 200.3 ± 30.0 -45.9 ± 9.7
Frequency (Hz) 
(n  = 6)
1 353.5 ± 27.2 324.6 ± 13.2 -7.2 ± 3.3
5 357.8 ± 25.7 282.4 ± 18.3 -19.7 ± 7.1
10 347.9 ± 23.0 219.7 ± 21.0 -35.2 ± 8.0
20 351.2 ± 29.0 164.5 ± 42.9 -50.0 ± 14.9
Pulse width (ms)
(n  = 6)
1 355.6 ± 28.5 278.1 ± 23.8 -20.4 ± 8.0
2 362.1 ± 30.4 244.8 ± 25.4 -29.7 ± 10.3
10 356.6 ± 25.5 227.1 ± 21.6 -34.4 ± 8.2
Atropine
(n  = 5)
Pre 354.9 ± 35.3 224.2 ± 25.0 -33.5 ± 11.0*
Post 333.8 ± 37.7 333.0 ± 37.9 -0.3 ± 0.2
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 1 
Supplemental Table 2. In vivo optogenetic versus electrical stimulation of the vagus nerve. 2 
Table corresponds to Figure 4. Frequency response curves summarizing the effects of 3 
optogenetic versus electrical stimulation of the right vagus nerve on heart rate in the intact state, 4 
of the caudal end following RVNx and BVNx, and of the cranial end following RVNx (t4 = 3.576, 5 
*P = 0.0232 at 10 Hz; t4 = 5.229, **P = 0.0064 at 20 Hz) and BVNx (t4 = 8.588, **P = 0.0010 at 20 6 
Hz). mean ± s.e.m.; paired, two-tailed t-test. 7 
 8 
Frequency (Hz)
(n  = 8)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
1 560.7 ± 5.5 552.5 ± 5.9 -1.5 ± 0.2 594.1 ± 4.4 587.9 ± 4.5 -1.0 ± 0.2
5 561.6 ± 6.6 533.6 ± 5.3 -5.0 ± 0.3 593.4 ± 5.5 556.0 ± 8.7 -6.3 ± 0.8
10 552.0 ± 8.0 481.6 ± 8.7 -12.8 ± 0.4 590.7 ± 6.1 509.5 ± 6.3 -13.8 ± 0.6
20 558.3 ± 6.3 401.3 ± 13.0 -28.1 ± 2.2 591.6 ± 5.7 370.3 ± 32.0 -37.7 ± 5.0
Frequency (Hz)
(n  = 3)
1 545.8 ± 12.9 535.9 ± 13.1 -1.8 ± 0.6 564.2 ± 8.9 555.3 ± 8.0 -1.6 ± 0.5
5 550.9 ± 11.5 501.5 ± 9.2 -9.0 ± 1.0 567.7 ± 7.9 519.9 ± 13.3 -8.4 ± 1.9
10 562.2 ± 8.2 459.6 ± 19.5 -18.3 ± 2.5 568.2 ± 4.6 449.2 ± 33.0 -21.0 ± 5.7
20 549.3 ± 11.5 302.9 ± 46.0 -44.9 ± 8.1 564.2 ± 7.4 276.2 ± 47.6 -51.0 ± 8.5
Frequency (Hz)
(n  = 3)
1 530.0 ± 6.6 516.4 ± 5.9 -2.6 ± 0.4 558.9 ± 7.1 548.3 ± 10.6 -1.9 ± 0.7
5 534.0 ± 2.7 493.6 ± 5.7 -7.5 ± 1.5 549.8 ± 10.6 508.3 ± 28.5 -7.7 ± 3.4
10 560.6 ± 6.4 478.2 ± 16.7 -14.7 ± 2.3 546.9 ± 9.5 457.2 ± 33.8 -16.5 ± 5.1
20 545.6 ± 3.0 370.8 ± 44.5 -32.0 ± 8.3 551.5 ± 8.1 354.4 ± 69.3 -36.1 ± 11.5
Frequency (Hz)
(n  = 5)
1 533.4 ± 10.6 531.2 ± 10.7 -0.4 ± 0.1 569.5 ± 13.0 568.2 ± 13.5 -0.2 ± 0.2
5 539.3 ± 11.0 536.9 ± 10.5 -0.4 ± 0.2 569.6 ± 14.1 559.0 ± 19.5 -2.0 ± 1.3
10 556.6 ± 12.9 556.0 ± 12.7 -0.1 ± 0.1* 576.1 ± 10.8 539.5 ± 18.8 -6.5 ± 1.8*
20 550.1 ± 12.1 549.3 ± 11.7 -0.1 ± 0.1** 576.1 ± 11.2 519.5 ± 17.3 -9.9 ± 1.8**
Frequency (Hz)
(n  = 5)
1 518.5 ± 7.4 519.7 ± 8.5 0.2 ± 0.2 546.7 ± 7.5 546.9 ± 8.0 0.0 ± 0.2
5 526.1 ± 9.0 525.5 ± 9.4 -0.1 ± 0.1 545.2 ± 9.1 545.9 ± 8.9 0.1 ± 0.1
10 547.4 ± 5.9 545.5 ± 5.5 -0.3 ± 0.2 542.4 ± 8.5 539.7 ± 11.0 -0.5 ± 0.5
20 535.7 ± 6.9 534.9 ± 7.2 -0.2 ± 0.1** 545.6 ± 7.8 528.3 ± 8.7 -3.2 ± 0.4**
BVNx cranial RVNS
Intact RVNS
Optical Electrical
RVNx caudal RVNS
BVNx caudal RVNS
RVNx cranial RVNS
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 1 
Supplemental Table 3. In vivo optogenetic stimulation of noradrenergic neurons in the 2 
RSG. Table corresponds to Figure 6. Dose response curves summarizing the effects of altering 3 
frequency and pulse width on heart rate. Summary of the heart rate response to stimulation of the 4 
RSG versus RT2G (t6 = 5.435, **P = 0.0016). Summary of the heart rate response to RSG 5 
stimulation before versus after propranolol administration (t3 = 3.951, *P = 0.0289). mean ± s.e.m.; 6 
paired, two-tailed t-test. 7 
 8 
Why is mixed recruitment of efferents/afferents by electrical stimulation more effective at rapidly 9 
increasing HR compared to optical pacing that is designed to only stimulate a pure population of 10 
nerves? Fig 4c - Given the relative delay in the optical versus electrical stimulation response, I 11 
wonder what is the evidence that the slower HR change with optical stimulation is not due to 12 
incomplete expression of the optically activated channel or a phased or delayed pattern of 13 
recruitment?  14 
 15 
We speculate that the more rapid decrease in heart rate with electrical compared to optogenetic 16 
stimulation is due to: 1) non-orderly fiber recruitment (as suggested by the reviewer) and 2) 17 
recruitment of both efferent and afferent fibers. In normal physiology, motor units are recruited in 18 
order of size, from small to large, with increasing levels of motor activation60,61. Electrical 19 
stimulation results in a non-physiological, non-orderly recruitment of motor units, activating large 20 
myelinated fibers before small myelinated fibers62-65. In contrast, Llewellyn et al. demonstrated 21 
that optogenetic stimulation results in physiological, orderly recruitment in the sciatic nerve (motor 22 
nerve that innervates the gastrocnemius muscle) of Thy1-ChR2-YFP mice62. Similar to our data, 23 
the authors observed longer latency from the initiation of nerve stimulation to depolarization on 24 
the gastrocnemius electromyogram and time required for contraction and relaxation of the 25 
gastrocnemius muscle with optogenetic compared to electrical stimulation. In addition to non-26 
orderly fiber recruitment, electrical stimulation activates both efferent and afferent fibers in the 27 
vagus nerve of ChAT-ChR2-eYFP mice, whereas optogenetics stimulation only activates efferent 28 
fibers. Our data shows that electrical stimulation of afferent fibers enhances efferent 29 
parasympathetic outflow and decreases heart rate following ipsilateral and bilateral vagotomy 30 
(Figure 4g and h, red line). Therefore, we believe that the heart rate response with electrical 31 
Frequency (Hz)
(n  = 7)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
1 464.8 ± 22.6 471.7 ± 22.1 1.5 ± 0.4
2 458.6 ± 21.3 476.2 ± 22.6 3.8 ± 0.6
5 459.6 ± 22.1 486.5 ± 20.6 6.1 ± 1.1
10 455.7 ± 20.8 499.5 ± 20.4 9.9 ± 1.8
20 462.4 ± 20.2 499.8 ± 18.3 8.3 ± 1.1
Pulse width (ms)
(n  = 6)
1 469.5 ± 37.5 482.9 ± 33.8 3.4 ± 1.6
2 475.0 ± 38.8 492.0 ± 35.3 4.1 ± 1.8
5 475.3 ± 36.3 500.4 ± 33.0 5.9 ± 2.4
10 464.2 ± 32.0 499.0 ± 31.2 7.9 ± 2.2
RSG versus RT2G
(n  = 7)
RSG 461.7 ± 24.2 504.1 ± 23.1 9.5 ± 1.8**
RT2G 486.1 ± 39.4 487.6 ± 39.3 0.3 ± 0.2
Propranolol
(n  = 4)
Pre 471.5 ± 23.4 498.0 ± 26.0 5.6 ± 1.4*
Post 364.1 ± 20.1 364.7 ± 20.5 0.1 ± 0.1
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stimulation of the intact vagus nerve (Figure 4c) is a cumulative response from activation of both 1 
efferent and afferent fibers, each of which is contributing to a reduction in heart rate. 2 
 3 
ChAT is a transferase enzyme required for the synthesis of acetylcholine, the primary 4 
neurotransmitter released by all cholinergic neurons. ChAT was used as a promoter to drive the 5 
expression of ChR2-eYFP in cholinergic neurons in ChAT-ChR2-eYFP mice. In these mice, we 6 
observed robust expression of ChR2-eYFP in the cervical vagus nerve (Figure 4b), and therefore, 7 
do not believe that incomplete ChR2-eYFP expression was a limitation. 8 
 9 
How do your results unravel the previous findings re electrical stimulation of the PV ganglia (i.e. 10 
bradycardia followed by tachycardia), as mentioned in the Discussion? 11 
 12 
Immunohistochemical studies have shown that cardiac ganglia such as those that are clustered 13 
around the pulmonary veins are a heterogeneous population, which includes parasympathetic, 14 
sympathetic, and sensory neurons66,67. Previous functional studies have shown that electrical 15 
stimulation of pulmonary vein ganglia result in a biphasic heart rate response of bradycardia 16 
followed by tachycardia10,68, likely due to activation of both parasympathetic and sympathetic 17 
neurons contained in the ganglia. In contrast to electrical stimulation, which lacks specificity, 18 
optogenetics allows for precise control of defined cell populations. Our data show the heart rate 19 
response with pure stimulation of cholinergic neurons in the IPV-GP—bradycardia without 20 
tachycardia—and highlight the importance of using precise tools to dissect cardiac neural 21 
circuitry. Future studies will use optogenetics to characterize the cardiovascular response to 22 
stimulation of different subpopulations of cardiac neurons including sensory neurons. 23 
 24 
The post vagotomy experiments with a different response to optical (none) and electrical (HR 25 
slowing) is fascinating. Nevertheless, I wonder how you can be sure it is not due to lack of 26 
adequate expression/capture/recruitment using the optical method? For example, an electrode 27 
recording showing an impulse with optical stimulation in the rostral limb of the severed vagus 28 
would strengthen your conclusion that the biology, rather than technical aspects of your approach, 29 
was driving your findings. 30 
 31 
As discussed above, ChAT is a transferase enzyme required for the synthesis of acetylcholine, 32 
the primary neurotransmitter released by all cholinergic neurons. ChAT was used as a promoter 33 
to drive the expression of ChR2-eYFP in cholinergic neurons in ChAT-ChR2-eYFP mice. In these 34 
mice, we observed robust expression of ChR2-eYFP in the cervical vagus nerve (Figure 4b), and 35 
therefore, do not believe that ChR2-eYFP expression was a limitation. The mouse cervical vagus 36 
nerve is approximately 100 µm in diameter69 and blue light attenuation is approximately 56% at a 37 
depth of 100 µm70. In our vagus nerve stimulation experiments, the average laser power for 38 
optogenetic stimulation was 77  6 mW. At a depth of 100 µm, a substantial laser power of 33 39 
mW was still delivered. Thus, we do not believe that fiber capture was a limitation either. 40 
 41 
The functional readout for our vagus nerve stimulation experiments was heart rate. In each ChAT-42 
ChR2-eYFP mouse, a significant decrease in heart rate was observed with electrical and 43 
optogenetic stimulation of the intact vagus nerve (Figure 4d). In the same animals, a change in 44 
heart rate was no longer observed with optogenetic stimulation following transection of the vagus 45 
nerve below the optical fiber (cranial/rostral vagus nerve stimulation) (Figure 4g and h, blue line). 46 
We have no reason to believe that the optogenetic stimulation was unable to capture or recruit 47 
fibers following transection in the same animals. Indeed, in a separate subset of animals, a 48 
significant decrease in heart rate was observed with optogenetic stimulation following transection 49 
of the vagus nerve above the optical fiber (caudal vagus nerve stimulation) (Figure 4e and f, blue 50 
line). Together, these data suggest that our findings are driven by biology and that the transection 51 
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did not affect the ability of the optogenetic stimulation to capture or recruit fibers due to nerve 1 
injury or other potential mechanisms. 2 
 3 
Recording compound action potentials from the mouse vagus nerve is technically challenging71. 4 
Even if we were able to obtain compound action potential recordings, we would expect to see no 5 
impulses with optogenetic stimulation of the cranial/rostral end of the vagus nerve following 6 
transection, since there is presumably no expression of ChR2-eYFP in the vagal afferent fibers. 7 
 8 
Paragraph 2, page 10 - The contrast between findings on sympathetic neurons in canines (post 9 
ganglionic neurons mostly in the middle cervical ganglia of the PV chain) versus mice (showing a 10 
craniomedial localization) might be due to species differences. 11 
 12 
We agree with the reviewer that there may be differences in neuronal organization across species. 13 
Interestingly, in small mammals (e.g., mouse, rats, guniea pigs) cardiac ganglia are located on 14 
the dorsal atrial wall11,12, whereas in large mammals (e.g., pigs, dogs, humans) cardiac ganglia 15 
are located in atrial and ventricular epicardial fat pads72-74. In future studies, we are planning on 16 
applying techniques described in this manuscript to larger animal models to characterize 17 
interspecies differences in cardiac innervation. 18 
 19 
Minor a minimum of 3 beats is excessively vague, arbitrary and, perhaps, insufficient to represent 20 
actual rates (i.e. 3 is a small number). 21 
 22 
We apologize for the vagueness of this statement. For heart rate, the average heart rate over a 23 
half a second was taken at baseline and during stimulation. For the P wave duration, 3 beats were 24 
measured at baseline and 3 beats were measured during simulation. This has been revised in 25 
the manuscript. 26 
 27 
 28 
Reviewer #3 (Remarks to the Author): 29 
 30 
In this well-written manuscript the authors present a novel tool for studying the role of 31 
parasympathetic and sympathetic nervous system in murine cardiac electrophysiology using 32 
optogenetics. They use parasympathetic and sympathetic specific Cre lines in combination with 33 
AAV driven fluorescent proteins to visualize the cardiac autonomic nervous system. Moreover, 34 
using tissue-specific ChR2 expression they specifically stimulate either the parasympathetic or 35 
sympathetic nervous system and investigated the effect on heart rate. The authors conclude to 36 
have provided novel insight into neural regulation of heart rate and tools for studying neuronal 37 
cardiac circuits or neural control of other organs. 38 
 39 
We thank the reviewer for careful reading of the manuscript and providing constructive comments. 40 
We have addressed the reviewer’s comments point-by-point below. 41 
 42 
comments 43 
 44 
The 3D visualizations of the neural circuit anatomy are beautiful but passive (movies showing pre-45 
defined angles and magnifications), it would be great if the authors could provide files where the 46 
user can decide at what angle and magnification the 3D reconstructions are visualized. Is this 47 
possible? 3D pdf for example? 48 
 49 
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All data from this manuscript including imaging data will be uploaded to the Stimulating Peripheral 1 
Activity to Relieve Conditions (SPARC) data repository and be made available to the public upon 2 
approval from the journal. 3 
 4 
In addition, we have setup our own webpage with an embedded volume viewer to visualize and 5 
manipulate some iDISCO-cleared hearts. The website address is: 6 
 7 
https://www.ics.uci.edu/~fowlkes/SPARC/volume/ 8 
 9 
We would also be glad to share entire raw imaging datasets of whole iDISCO-cleared hearts with 10 
the reviewer. However, these datasets are large (~100 gb) 11 
 12 
Figure 2 and labeling of the cholinergic neurons. This part is confusing. Please explain the function 13 
of the human Synapsin I promotor. What is the reason for using the two-component expression 14 
system? Please elaborate.  15 
 16 
Human Synapsin I (hSyn1) is localized to the nerve terminals of axons and plays a role in 17 
neurotransmitter release. The hSyn1 promoter limits expression to neurons and is a widely-used 18 
pan-neuronal promoter16,75,76. 19 
 20 
A two-component AAV system was used to control the labeling density16. The two-component 21 
system consists of an expression vector (e.g., ssAAV-PHP.S:TRE-DIO-XFPs in Figure 2) 22 
delivered at a high dose and an inducer vector (ssAAV-PHP.S:ihSyn1-DIO-tTA) delivered at a 23 
variable dose. The expression of the gene of interest (e.g., fluorescent proteins (XFPs)) in a cell 24 
is dependent on co-transduction by the inducer vector. By varying the dose of the inducer vector, 25 
gene expression can be titrated. With the dense labeling (Figure 2a), anatomical tracing of nerve 26 
fibers is challenging because of the close apposition of fibers in nerve bundles. However, with the 27 
two-component expression system, we were able to reduce the fraction of labeled cells and trace 28 
individual fibers (Figure 2b and c). More specific details about the two-component system are 29 
available in prior publications by our group16,75. 30 
 31 
Why not placing Cre directly under control of the Synapsin I promotor? Figure 2c shows results 32 
of an entirely different expression system. Please explain. 33 
 34 
We used Cre-dependent AAVs and ChAT-IRES-Cre transgenic mice to restrict the expression of 35 
the fluorescent reporter genes to cholinergic neurons as we were interested in tracing this 36 
subpopulation of cardiac neurons. If Cre was placed under the control of the Synapsin I promoter 37 
(i.e., Syn1-Cre), the fluorescent reporter genes would be expressed in all neurons and not just 38 
cholinergic neurons. 39 
 40 
How did the authors verify that labeling was indeed restricted to the cholinergic neurons? Low 41 
levels of Cre expression outside these neurons would generate aspecific labeling. Please provide 42 
additional data verifying specificity using an independent marker. 43 
 44 
We performed additional immunohistochemistry to address the reviewer’s comment. Please see 45 
Response Figure 3 and Supplemental Figure 3. In ChAT-IRES-Cre mice injected with ssAAV-46 
PHP.S:CAG-DIO-eYFP, GFP expression was highly specific for cholinergic neurons in cardiac 47 
ganglia (100.0  0.0% of GFP+ neurons were ChAT+) (Supplemental Figure 3d and e). 48 
 49 
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 1 
Response Figure 3. ssAAV-PHP.S:CAG-DIO-eYFP was systemically administered to ChAT-2 
IRES-Cre mice at 1 x 1012 vg per mouse. Three weeks later, eYFP fluorescence was assessed. 3 
Representative single-plane confocal images of a cardiac ganglion with native eYFP signal 4 
(green) and ChAT (red) and GFP (magenta) staining. Scale bar is 50 µm. 5 
 6 
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 1 
Supplemental Figure 3. AAV-PHP.S preferentially transduces peripheral versus central 2 
cholinergic neurons. ssAAV-PHP.S:CAG-DIO-eYFP was systemically administered to ChAT-3 
IRES-Cre mice at 1 x 1012 vg per mouse. Three weeks later, eYFP fluorescence was assessed 4 
using an antibody for GFP. (a) Single-plane confocal images of the medulla (left) and dorsal motor 5 
nucleus of the vagus nerve (DMV) (right) whole-mount stained with ChAT (red) and GFP (green). 6 
White dashed ovals in the medulla show the location of the DMV. White dashed boxes in the DMV 7 
images indicate location of higher magnification images in white boxes. (b) Percentage of DMV 8 
neurons expressing GFP and ChAT over those expressing ChAT. (c) MIP images of the 9 
nodose/jugular ganglion complex whole-mount stained with PGP9.5 (red) and GFP (green). (d) 10 
MIP images of a cardiac ganglion from a heart whole-mount stained with PGP9.5 (red) and GFP 11 
(green). White dashed boxes indicate location of higher magnification images in white boxes. (e) 12 
Percentage of cardiac ganglion neurons expressing GFP and ChAT over those expressing GFP 13 
or ChAT, indicating specificity or efficiency of viral transduction, respectively. n = 4 mice (b) and 14 
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5 mice (e); mean ± s.e.m.. Scale bars are 500 µm (a (left)), 100 µm (a (right), c, d (right), and 1 1 
mm (d (left)). 2 
 3 
The authors use multiple fluorescent proteins to visualize the parasympathetic nervous system. 4 
Please explain why.  5 
 6 
Most, if not all, commercially available antibodies against ChAT recognize a central rather than 7 
peripheral isoform of ChAT, labeling peripheral cholinergic neurons weakly18. An antibody has 8 
been developed against the peripheral isoform of ChAT19; however, it is not yet commercially 9 
available. Therefore, we used antibody against ChAT in the medulla in the central nervous system 10 
and an antibody against PGP9.5 as a surrogate for ChAT in cardiac ganglia in the peripheral 11 
nervous system due to the weak labeling and high background associated with ChAT staining in 12 
the periphery. We performed additional immunohistochemistry that shows strong colocalization 13 
of GFP with ChAT in ChAT-IRES-Cre mice injected with ssAAV-PHP.S:CAG-DIO-eYFP. These 14 
data are included in the above response and in Supplemental Figure 3. 15 
 16 
Figure 2D. It is unclear how the sections are oriented. I suggest to add an overview section 17 
indicating the location of the sections shown. Moreover, Hcn4 is used to mark the Sinus node and 18 
AV node. To me, however, the Hcn4 staining seems stronger outside the areas marked with the 19 
dashed white lines than inside. The AV node does not seem to be labeled. Please address this 20 
issue.  21 
 22 
A cartoon depicting orientation of the section has been added to Figure 2c. HCN4 is the best 23 
available marker to identify the SA node and AV node. While HCN channels are expressed 24 
predominately within the cardiac conduction system (SA node, AV node, and His bundle), they 25 
are also expressed to a lesser extent outside of the conduction system in atrial and ventricular 26 
myocardial tissue77. Therefore, we relied primarily on anatomical landmarks (i.e. sulcus terminalis 27 
and superior vena cava for the SA node; base of the right atrium and interatrial septum for AV 28 
node), in addition to HCN4 immunostaining, to identify the SA node and AV node. 29 
 30 
Page 5. The authors use ChR2-enhanced yellow fluorescent protein but switch to GFP in their 31 
descriptions, which is confusing. 32 
 33 
We apologize for the confusion. A widely-used antibody against GFP (Aves Labs, GFP-1020; 545 34 
citations on CiteAb) was utilized to amplify the detection of endogenous ChR2-eYFP signals. For 35 
all quantifications, GFP expression was used. 36 
 37 
“rostral” is archaic, cranial or anterior is more commonly used. 38 
 39 
We now use cranial rather than rostral in the manuscript. 40 
 41 
Figure 4 C. The authors compare optical stimulation of the right vagal nerve with electrical 42 
stimulation of the right vagal nerve. The approaches differ in 2 ways. 1) Only a part of the RVNS 43 
is stimulated optically whereas the whole RVNS is stimulated during electrical stimulation, and 2) 44 
optical stimulation in itself differs from electrical stimulation. Why didn’t the authors compare 45 
electrical stimulation with optical stimulation of both the efferent and afferent fibers in the vagal 46 
nerve? This allows for discriminating the different responses to the different approaches. 47 
 48 
We thank the reviewer for this insightful question. To the best of our knowledge, pan-neuronal 49 
Cre knock-in mouse lines have not been well characterized in the peripheral nervous system. 50 
Therefore, we used a validated ChAT-IRES-Cre line78,79 for our optogenetic studies. As better 51 
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transgenic mouse models are generated these studies will be expanded. Furthermore, we are 1 
currently developing intersectional tools to deliver genes of interest (e.g., fluorescent reporter 2 
proteins, opsins) to heart-specific efferent and afferent fibers of the vagus. Future studies will 3 
focus on optogenetic stimulation of heart-specific vagal efferents and afferents. 4 
 5 
The authors report p wave fractionation during IPV-GP stimulation. Do the authors mean a 6 
biphasic p wave? It is known that the right and left atrium activation with a delay of about 5 ms. 7 
The activation wave propagates from the right atrium towards the left atrium via a dorsal 8 
myocardial connection. Do the authors think this delay between right and left atrium is increased 9 
during IPV-GP stimulation? Or does IPV-GP stimulation affect atrial conduction?  10 
 11 
In some instances, a biphasic P wave was noted, which as the reviewer mentions, reflects impulse 12 
propagation from the right to left atria. However, we noted increases in P wave duration as well 13 
as changes in morphology during IPV-GP stimulation (Response Figure 8). The prolongation of 14 
P wave duration does suggest that increased time is required to depolarize the atria with 15 
optogenetic stimulation of the IPV-GP. Fractionated atrial electrograms are thought to indicate 16 
conduction slowing or block and sites for autonomic innervation and are thought to reflect the 17 
structural and functional properties of the atrial myocardium80,81. Indeed, in human patients 18 
undergoing atrial fibrillation ablation, our group has previously shown that pharmacologic 19 
stimulation of the cardiac parasympathetic nerves causes fractionation of atrial electrograms 20 
during sinus rhythm82. The contribution of autonomic nervous system to fractionation of atrial 21 
electrograms has also been shown in a canine model83. We are not able to state whether the 22 
fractionation in the atrial electrograms were due to slowed conduction or altered conduction 23 
pathways. 24 
 25 
 26 
Response Figure 8. Example of a cardiac electrogram at baseline and during stimulation of the 27 
IPV-GP. Note in both cases the P waves (shown in the gray dashed boxes) were biphasic but 28 
during stimulation the P wave was longer in duration and fractionated. 29 
 30 
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Page 5 line 31. The authors mention that the nerve fiber passes through the AV node but does 1 
not synapse. Where is the nerve going? Was ventricular conduction affected? 2 
 3 
While synapses were not visualized in our study, it is possible that fibers from the IPV-GP pass 4 
through the AV node region and synapse on neighboring atrial or ventricular myocardium. 5 
 6 
The focus of our manuscript was on identifying cholinergic and noradrenergic neurons involved 7 
in heart rate regulation and not in control of ventricular electrophysiology. However, in a subset 8 
of ChAT-ChR2-eYFP mice, we performed dual optical mapping of membrane voltage (Vm) and 9 
intracellular Ca2+ transients (CaT) of the heart during optogenetic stimulation of the IPV-GP 10 
(Response Figure 9a). We observed atrial and ventricular changes in Vm and CaT activation maps 11 
during stimulation (Response Figure 9b) and a trend towards an increase in the Vm and CaT delay 12 
at the atria and base of the heart (Response Figure 9c and d). Future studies should focus on 13 
cholinergic and noradrenergic control of ventricular electrophysiology. 14 
 15 
 16 
Response Figure 9. Optical mapping of ex vivo heart during optogenetic stimulation of 17 
cholinergic neurons in the IPV-GP. (a) Image of the dorsal side of a ChAT-ChR2-eYFP mouse 18 
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heart showing the position of a laser-coupled optical fiber used for focal illumination of the IPV-1 
GP (circle). (b) Representative isochronal calcium transient (CaT) activation maps before and 2 
immediately after stimulation. (c) Representative membrane voltage (Vm) and CaT signals from 3 
the atria (top) and base of the heart (bottom) before (left) and immediately after stimulation (right). 4 
(d) Summary of the delay between Vm and CaT signals before versus immediately after 5 
stimulation in the atria (t2 = 2.980, P = 0.0965) (top) and base of the heart (t2 = 3.022, P = 0.0943) 6 
(bottom). n = 3 mice (d); mean ± s.e.m.; paired, two-tailed t-test. Scale bar is 1 mm (a). 7 
 8 
On page 7 Figure 4G is discussed before Figure 4F. Please adjust the figure order to the text.  9 
 10 
We have made this correction in the manuscript. 11 
 12 
On page 8 and Figure 6, please provide validation of the specificity of the TH Cre driver. 13 
 14 
The paravertebral ganglia including the stellate ganglia primarily contain the cell bodies of 15 
sympathetic postganglionic neurons. TH is the rate-limiting enzyme in the production of 16 
norepinephrine and is a widely-used marker of sympathetic neurons. We counted an average of 17 
291 ± 62 stellate ganglion neurons from 6 TH-ChR2-eYFP mice. GFP expression was highly 18 
specific for TH+ neurons in the stellate ganglia (98.7 ± 0.4% of GFP+ neurons were TH+) and all 19 
TH+ neurons were GFP+ (100.0 ± 0.0%) (Figure 6c and Response Figure 10). 20 
 21 
 22 
Response Figure 10. ChR2-EYFP expression in stellate ganglion of TH-ChR2-eYFP mice. 23 
(a) Representative single-plane confocal images of a stellate ganglion from a TH-ChR2-eYFP 24 
mouse whole-mount stained with TH (red) and GFP (green). Inset shows a neuron that is TH- 25 
and GFP+. (b) Percentage of stellate ganglion neurons expressing GFP and TH over those 26 
expressing GFP or TH. Scale bar is 50 µm. n = 6 mice (b). 27 
 28 
Discussion conclusion 3, it is not clear how the authors arrive at this conclusion. Please better 29 
explain. “central mechanisms”? 30 
 31 
Our functional data demonstrate that activation of vagal afferent fibers decreases heart rate 32 
(Figure 4g and h). Anatomical studies have shown that vagal afferent neurons synapse on 33 
neurons in the nucleus tractus solitarii (NTS) in the medulla in the brainstem84. Neurons in the 34 
NTS then project to vagal nuclei (nucleus ambiguus and dorsal motor nucleus) in the medulla to 35 
modulate parasympathetic efferent outflow84 and to sympathetic nuclei (rostral ventrolateral 36 
medulla) in the medulla to modulate sympathetic efferent flow85. Consistent with previous studies 37 
 
26 
on the classic vasovagal reflex (Bezold-Jarish reflex)86-88, we speculate that vagal afferents act 1 
on central nuclei to decrease heart rate by increasing parasympathetic efferent outflow and 2 
decreasing sympathetic efferent outflow. Further, the decrease in heart rate with electrical 3 
stimulation of vagal afferents following bilateral vagotomy (Figure 4h) is evidence that vagal 4 
afferent stimulation decreases sympathetic efferent outflow to the heart, since vagal efferent 5 
pathways were transected. Therefore, vagal afferent-mediated effects on heart rate must be 6 
relayed through the central nervous system. 7 
 8 
References: In some cases the author list is abbreviated and in other case it is not. Please adjust 9 
to the correct style. 10 
 11 
We used the Nature referencing style. In the Nature referencing style, all authors are included in 12 
reference lists unless there are six or more authors in which case only the first author is given, 13 
followed by 'et al.'. 14 
 15 
 16 
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